A detailed history of Stillwater Wealth Management Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Stillwater Wealth Management Group holds 15,439 shares of ABBV stock, worth $2.87 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares
15,439
Holding current value
$2.87 Million
% of portfolio
2.46%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Apr 14, 2025

BUY
$164.99 - $203.87 $2.55 Million - $3.15 Million
15,439 New
15,439 $2.74 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $329B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Stillwater Wealth Management Group Portfolio

Follow Stillwater Wealth Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stillwater Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Stillwater Wealth Management Group with notifications on news.